1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis grant supports the research of outstanding early career members of Division 7 who have not yet received any federal funding for research as a principal investigator or co-investigator.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible assistant professors (pretenure or no more than 2 years post-tenure) and postdoctoral scholars (within five years past receipt of the doctoral degree). Membership in APA's Division 7 is required. Confirm the full requirements in the official notice before applying.
The current listing shows $1,000 (one or two awards per year). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Early Career Research Grant in Developmental Psychology are due November 1, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Early Career Research Grant in Developmental Psychology is funded by American Psychological Association (APA) Division 7. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
The Merck Stimulating Innovative Research Grant Program 2026 includes a dedicated grant topic for artificial intelligence in cell culture media and process development, offering up to EUR 150,000 per year for up to 3 years. The program accelerates innovation through collaborative research, early engagement with industry experts, and translation of novel ideas into practical solutions. In 2026, priority areas also include in-vitro models for neuroinflammatory diseases (EUR 250,000/year for 2 years) and innovative approaches to contaminated materials remediation (EUR 150,000/year for 2 years). The two-stage application process begins with non-confidential submissions, followed by deep-dive workshops where finalists collaborate with Merck scientists and managers to jointly optimize proposals. The AI-specific grant focuses on applying machine learning and AI to optimize cell culture media formulation, bioprocess parameter optimization, and manufacturing quality control.
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed. Funding Opportunity Number: HT942526DMDRPIDA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.5M total program funding.
Five weeks after a federal judge vacated the FY2026 Continuum of Care NOFO in its entirety, HUD published a Notice of Research Justifying Additional Incentives for Certain Activities To Reduce Homelessness. It is not a NOFO and not a proposed rule — it is the administrative record HUD needs to reissue the same policy and survive the next lawsuit. Here is what the four named activities tell you about the revised competition, why the October 13 comment deadline is now the real leverage point, and what CoC leads should be building right now.
Read articleOn August 7, 2026, Judge Mary S. McElroy vacated HUD's FY2026 Continuum of Care NOFO in full, finding the agency violated the Administrative Procedure Act by skipping notice-and-comment before setting aside roughly $1.3 billion — nearly a third of CoC funding — for new projects. HUD has appealed and been denied an emergency stay. Here is what the ruling actually does to renewals, what Congress already guaranteed, and what CoC leads and subrecipients should be doing during the pause.
Read article